Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

The protocol describes a method for introducing controllable genetic diversity in the hepatitis C virus genome by combining full-length mutant RNA synthesis using error-prone PCR and reverse genetics. The method provides a model for phenotype selection and can be used for 10 kb long positive-sense RNA virus genomes.

Streszczenie

The lack of a convenient method for the iterative generation of diverse full-length viral variants has impeded the study of directed evolution in RNA viruses. By integrating a full RNA genome error-prone PCR and reverse genetics, random genome-wide substitution mutagenesis can be induced. We have developed a method using this technique to synthesize diverse libraries to identify viral mutants with phenotypes of interest. This method, called full-length mutant RNA synthesis (FL-MRS), offers the following advantages: (i) the ability to create a large library via a highly efficient one-step error-prone PCR; (ii) the ability to create groups of libraries with varying levels of genetic diversity by manipulating the fidelity of DNA polymerase; (iii) the creation of a full-length PCR product that can directly serve as a template for mutant RNA synthesis; and (iv) the ability to create RNA that can be delivered into host cells as a non-selected input pool to screen for viral mutants of the desired phenotype. We have found, using a reverse genetics approach, that FL-MRS is a reliable tool to study viral-directed evolution at all stages in the life cycle of the hepatitis C virus, JFH1 isolate. This technique appears to be an invaluable tool to employ directed evolution to understand adaptation, replication, and the role of viral genes in pathogenesis and antiviral resistance in positive-sense RNA viruses.

Wprowadzenie

Forward genetic screening begins with a viral phenotype of interest and then, through sequencing its genome and comparing it to that of the original strain, attempts to identify the mutation(s) causing that phenotype. In contrast, in reverse genetic screens, random mutations are introduced in a target gene, followed by an examination of the resultant phenotype(s)1. For the reverse genetics approach, in vitro mutagenesis is the most widely used technique to create a pool of variants that are subsequently screened for phenotypes of interest. Various genetic tools have been reported for achieving genome-wide random mutagenesis of RNA viru....

Protokół

NOTE: The JFH1 strain (WT) used here was a kind gift from Takaji Wakita, National Institute of Infectious Diseases. The human hepatoma cell line, Huh7.5, was a kind gift from Charles Rice, The Rockefeller University. A schematic of the method is shown in Figure 1.

1. Genome-wide substitution mutagenesis of JFH1 using error-prone PCR

  1. To perform ep-PCR, prepare the master mix for four sets of experiments with primers J-For 5'-GTTTTCCCAGTCAGCACGTTGTAAAACGACGGC-3' and J-Rev 5'-CATGATCTGCAGAGAGACCAGTTACGGCACTCTC -3' (Figure 1A), along with th....

Wyniki

A plethora of full-length HCV variants can be generated and screened for drug-resistant phenotypes of interest following the procedures described in Figure 1. Full genome mutant libraries were synthesized using clonal-pJFH1 in decreasing amounts (100-10 ng), as shown in Figure 2. Average yields of ep-PCR products (mutant libraries) ranged from 3.8-12.5 ng/µL. Figure 3 shows the viral transcripts synthesized from the clonal-pJFH.......

Dyskusje

In this study, we have detailed a simple and rapid FL-MRS procedure that integrates ep-PCR18 and reverse genetics for synthesizing HCV full-genome libraries, which can then be used in a cell culture system to generate replication-competent variants for the screening of drug-resistant phenotypes. The use of low-fidelity Taq DNA polymerase is a prerequisite of ep-PCR that allows the incorporation of substitutions during PCR amplification of a full-length viral genome. We tested several low-fidelity .......

Ujawnienia

The authors have nothing to disclose.

Podziękowania

Funding support (grant number BT/PR10906/MED/29/860/2014) for this study was provided by the Department of Biotechnology, Government of India.

....

Materiały

NameCompanyCatalog NumberComments
1 kb plus DNA ladder Thermo Fisher10787018
1.5 ml centrifuge tubeTarsons500010
15 ml centrifuge tubeTarsons546021
35 mm cell culture dish Tarsons960010
50 ml centrifuge tubeTarsons546041
Acetic acidMerckA6283
Agarose HiMediaMB080
Agrose gel electrophoresis unitBioRad1704406
Biosafety Cabinet, ClassIIESCOAC2 4S
Bovine serum albuminHiMediaMB083
Centrifuge Eppendorf5424-R
CFX Connect Real-Time PCR Detection SystemBioRad1855201
Cloning plates 90 mm Tarson460091
CO2 Incubator New BrunswickGalaxy 170R
Colibri Microvolume SpectrometerTitertek-Berthold11050140
DAB Substrate Kit Abcamab94665
dATP SolutionNEBN0440S
Deoxynucleotide (dNTP) Solution SetNEBN0446
Diethyl Pyrocarbonate (DEPC) SRL chemical46791
Dimethyl sulphoxide (DMSO)HiMediaMB058
DMEM high glucoseLonzaBE12-604F
EcoR1-HFNEBR3101
EDTA tetrasodium salt dihydrateHiMediaGRM4918
Ethidium BromideAmrescoX328
Fetal bovine serum Gibco26140079
Formaldehyde Fishser Scientific12755
Gel Documentation SystemALPHA IMAGER
Goat anti-Mouse IgG (H+L) Secondary Antibody, HRPThermo FisherA16066
Hydrogen peroxide 30%Merck107209
Inverted microscopeNickon ECLIPSE Ts2
LB broth HiMediaM1245
Lipofectamine 2000 Thermo Fisher116680270transfection reagent
Mechanical Pipette SetEppendorf  3120000909
MethanolMerck106009
Micro Tips 0.2-10 µl Tarsons521000
Micro Tips 10 - 100 µl Tarsons521010
Micro Tips 200-1000 µl Tarsons521020
MOPS buffer GeNei3601805001730
Nonessential aminoacids (NEAA)Gibco11140050
One Shot TOP10 Chemically Competent E. coliInvitrogenC404010E.coli DH5α
Opti-MEMGibco1105-021minimal essential medium
PCR tubes 0.2 mlTarsons510051
Pencillin/streptomycin Gibco15070063
pGEM-T Easy Vector SystemPromegaA1360T-vector DNA
Phosphate buffer saline (PBS)HiMediaTI1099
Phusion High-Fidelity DNA PolymeraseNEBM0530S
PibrentasvirCayman Chemical27546
Pipette controller Gilson F110120
Platinum Taq DNA Polymerase Thermo10966034
PrismGraphPadstatistical analysis software
QIAamp Viral RNA Mini kit Qiagen52904viral isolation kit
QIAprep Spin Miniprep KitQiagen27106
QIAquick PCR Purification KitQIAGEN28104cokum purification kit
RNeasy Mini Kit QIAGEN74104RNA cleanup kit
Serological Pipettes 25 mlThermo Fisher170357N
Serological Pipettes 5 mlThermo Fisher170355N
Serological Pipettes10 mlThermo Fisher170356N
Single strand RNA Marker 0.2-10 kbMerckR7020
Skim milk HiMediaM530
Sodium azide 0.1 M solutionMerck8591
SuperScript III Reverse Transcriptase Invitrogen18080044reverse transcriptase
T100 Thermal CyclerBioRad1861096
T175 cell culture flask Tarsons159910
T25 cell culture flask Tarsons950040
T7 RiboMax Express Large Scale RNA Production System PromegaP1320 Large Scale RNA Production System 
T75 cell culture flask Tarsons950050
Taq DNA PolymeraseGenetix Biotech (Puregene)PGM040
TaqMan RNA-to-CT 1-Step KitApplied Biosystems4392653
TaqMan RNA-to-CT 1-Step KitThermo Fisher4392653commercial qRT-PCR kit 
TOPO-XL--2 Complete PCR Cloning KitThermo FisherK8050-10kit for cloning of long-PCR product 
Tris baseHiMediaTC072
Trypsin-EDTA solutionHiMediaTCL007
Tween 20HiMediaMB067
Vacuum Concentrator Eppendorf, Concentrator Plus100248
Water bath GRANTJBN-18
Xba1NEBR0145S

Odniesienia

  1. Desselberger, U. Reverse genetics of rotavirus. Proceedings of the National Academy of Sciences of the United States of America. 114 (9), 2106-2108 (2017).
  2. Singh, D., et al. Genome-wide mutagenesis of hepatitis C virus....

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Reverse GeneticsPositive sense RNA VirusViral GenomeMutagenesisRNA LibraryPhenotype SelectionCloning freeEp PCRIn Vitro RNA SynthesisCDNA SynthesisAmplificationA Overhang Addition

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone